Annual CFO
-$33.27 M
+$8.41 M+20.17%
December 31, 2023
Summary
- As of February 7, 2025, SPRB annual cash flow from operations is -$33.27 million, with the most recent change of +$8.41 million (+20.17%) on December 31, 2023.
- During the last 3 years, SPRB annual CFO has fallen by -$5.76 million (-20.92%).
- SPRB annual CFO is now -288.27% below its all-time high of -$8.57 million, reached on December 31, 2018.
Performance
SPRB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$9.22 M
+$1.88 M+16.95%
September 30, 2024
Summary
- As of February 7, 2025, SPRB quarterly cash flow from operations is -$9.22 million, with the most recent change of +$1.88 million (+16.95%) on September 30, 2024.
- Over the past year, SPRB quarterly CFO has increased by +$1.99 million (+17.72%).
- SPRB quarterly CFO is now -562.77% below its all-time high of $1.99 million, reached on June 30, 2023.
Performance
SPRB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$46.50 M
+$3.05 M+6.15%
September 30, 2024
Summary
- As of February 7, 2025, SPRB TTM cash flow from operations is -$46.50 million, with the most recent change of +$3.05 million (+6.15%) on September 30, 2024.
- Over the past year, SPRB TTM CFO has dropped by -$13.22 million (-39.73%).
- SPRB TTM CFO is now -680.66% below its all-time high of -$5.96 million, reached on March 31, 2020.
Performance
SPRB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SPRB Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +20.2% | +17.7% | -39.7% |
3 y3 years | -20.9% | +17.7% | -39.7% |
5 y5 years | -288.3% | +17.7% | -39.7% |
SPRB Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +20.2% | -562.8% | +38.3% | -54.4% | +6.2% |
5 y | 5-year | -163.7% | +20.2% | -562.8% | +38.3% | -680.7% | +6.2% |
alltime | all time | -288.3% | +20.2% | -562.8% | +38.3% | -680.7% | +6.2% |
Spruce Biosciences Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$9.22 M(-17.0%) | -$46.50 M(-6.1%) |
Jun 2024 | - | -$11.11 M(-25.8%) | -$49.54 M(+35.9%) |
Mar 2024 | - | -$14.96 M(+33.4%) | -$36.44 M(+9.5%) |
Dec 2023 | -$33.27 M(-20.2%) | -$11.21 M(-8.6%) | -$33.27 M(-1.6%) |
Sep 2023 | - | -$12.27 M(-715.6%) | -$33.80 M(+12.3%) |
Jun 2023 | - | $1.99 M(-116.9%) | -$30.11 M(-27.7%) |
Mar 2023 | - | -$11.79 M(+0.4%) | -$41.65 M(-0.1%) |
Dec 2022 | -$41.68 M | -$11.74 M(+36.8%) | -$41.68 M(+4.9%) |
Sep 2022 | - | -$8.58 M(-10.1%) | -$39.74 M(+2.5%) |
Jun 2022 | - | -$9.54 M(-19.3%) | -$38.76 M(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$11.83 M(+20.7%) | -$38.92 M(+8.5%) |
Dec 2021 | -$35.88 M(+30.4%) | -$9.80 M(+29.0%) | -$35.88 M(+1.5%) |
Sep 2021 | - | -$7.60 M(-21.6%) | -$35.34 M(0.0%) |
Jun 2021 | - | -$9.69 M(+10.3%) | -$35.34 M(+16.5%) |
Mar 2021 | - | -$8.79 M(-5.2%) | -$30.35 M(+10.3%) |
Dec 2020 | -$27.52 M(+118.1%) | -$9.27 M(+22.0%) | -$27.52 M(+50.8%) |
Sep 2020 | - | -$7.60 M(+61.6%) | -$18.25 M(+71.3%) |
Jun 2020 | - | -$4.70 M(-21.1%) | -$10.66 M(+78.9%) |
Mar 2020 | - | -$5.96 M | -$5.96 M |
Dec 2019 | -$12.62 M(+47.2%) | - | - |
Dec 2018 | -$8.57 M | - | - |
FAQ
- What is Spruce Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Spruce Biosciences?
- What is Spruce Biosciences annual CFO year-on-year change?
- What is Spruce Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Spruce Biosciences?
- What is Spruce Biosciences quarterly CFO year-on-year change?
- What is Spruce Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Spruce Biosciences?
- What is Spruce Biosciences TTM CFO year-on-year change?
What is Spruce Biosciences annual cash flow from operations?
The current annual CFO of SPRB is -$33.27 M
What is the all time high annual CFO for Spruce Biosciences?
Spruce Biosciences all-time high annual cash flow from operations is -$8.57 M
What is Spruce Biosciences annual CFO year-on-year change?
Over the past year, SPRB annual cash flow from operations has changed by +$8.41 M (+20.17%)
What is Spruce Biosciences quarterly cash flow from operations?
The current quarterly CFO of SPRB is -$9.22 M
What is the all time high quarterly CFO for Spruce Biosciences?
Spruce Biosciences all-time high quarterly cash flow from operations is $1.99 M
What is Spruce Biosciences quarterly CFO year-on-year change?
Over the past year, SPRB quarterly cash flow from operations has changed by +$1.99 M (+17.72%)
What is Spruce Biosciences TTM cash flow from operations?
The current TTM CFO of SPRB is -$46.50 M
What is the all time high TTM CFO for Spruce Biosciences?
Spruce Biosciences all-time high TTM cash flow from operations is -$5.96 M
What is Spruce Biosciences TTM CFO year-on-year change?
Over the past year, SPRB TTM cash flow from operations has changed by -$13.22 M (-39.73%)